“Nobody Wants A Synthetic-Only Future”: Filament Health Is Formulating Natural Psilocybin And Standardizing Ayahuasca
Filament Health CEO Ben Lightburn discusses the challenges of producing natural extracts for psychedelic therapy.
Read MoreFilament Health CEO Ben Lightburn discusses the challenges of producing natural extracts for psychedelic therapy.
Read MoreWhat is a k-hole? This guide explains the possible “ego-dissolution” that comes from ketamine.
Read MoreCan the use of psychedelics in therapy settings change mental health as we know it?
Read MoreBusinessman Klee Irwin explains his plan to “bring psychedelics therapy to the masses.”
Read MoreThe Netflix mini series "How To Change Your Mind" has everyone talking about psychedelics. These are our biggest takeaways.
Read MoreCanada's Special Access Program (SAP) helped a cancer patient receive legal psilocybin therapy for the first time ever.
Read MoreResearch suggests using psychedelics for eating disorders could be effective. Dr. Reid Robison explains why.
Read MorePsychedelic integration is a critical part of the psychedelic experience. This guide helps explain why.
Read MoreMike Wilson's a gaming savant, but with a history of depression, he found psychedelic therapy was his way to find
Read MoreWe explain what a psychedelic therapy container is, and why it's critical while using psychedelics as medicine.
Read More